BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12967336)

  • 21. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.
    El Fahime E; Mills P; Lafreniere JF; Torrente Y; Tremblay JP
    Exp Cell Res; 2002 Nov; 280(2):169-78. PubMed ID: 12413883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function.
    Susarla R; Watkinson JC; Eggo MC
    J Cell Physiol; 2007 Sep; 212(3):643-54. PubMed ID: 17458906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased bone formation in mice lacking plasminogen activators.
    Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P; Persson E; Conaway HH; Lerner UH
    J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mouse testis is the source of various serine proteases and serine proteinase inhibitors (SERPINs): Serine proteases and SERPINs identified in Leydig cells are under gonadotropin regulation.
    Odet F; Verot A; Le Magueresse-Battistoni B
    Endocrinology; 2006 Sep; 147(9):4374-83. PubMed ID: 16740973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
    Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmin-independent gelatinase B (matrix metalloproteinase-9) release by monocytes under the influence of urokinase.
    Menshikov MY; Elizarova EP; Kudryashova E; Timofeyeva AV; Khaspekov Y; Beabealashvilly RS; Bobik A
    Biochemistry (Mosc); 2001 Sep; 66(9):954-9. PubMed ID: 11703174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function.
    Furlan F; Galbiati C; Jorgensen NR; Jensen JE; Mrak E; Rubinacci A; Talotta F; Verde P; Blasi F
    J Bone Miner Res; 2007 Sep; 22(9):1387-96. PubMed ID: 17539736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator.
    Magdolen V; Arroyo de Prada N; Sperl S; Muehlenweg B; Luther T; Wilhelm OG; Magdolen U; Graeff H; Reuning U; Schmitt M
    Adv Exp Med Biol; 2000; 477():331-41. PubMed ID: 10849761
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activator system in osteoclasts.
    Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C
    J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
    J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.